The latest Investing Matters Podcast episode with Inclusive Asset Management's Alexandra McGuigan has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTotally Regulatory News (TLY)

Share Price Information for Totally (TLY)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 4.60
Bid: 4.20
Ask: 5.00
Change: 0.00 (0.00%)
Spread: 0.80 (19.048%)
Open: 4.60
High: 4.60
Low: 4.60
Prev. Close: 4.60
TLY Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Schedule One - Totally PLC

6 Oct 2017 08:00

RNS Number : 9151S
AIM
06 October 2017
 

 

ANNOUNCEMENT TO BE MADE BY THE AIM APPLICANT PRIOR TO ADMISSION IN ACCORDANCE WITH RULE 2 OF THE AIM RULES FOR COMPANIES ("AIM RULES")

COMPANY NAME:

Totally plc

 

COMPANY REGISTERED OFFICE ADDRESS AND IF DIFFERENT, COMPANY TRADING ADDRESS (INCLUDING POSTCODES):

 

Hamilton House

Mabledon Place

London

WC1H 9BB

United Kingdom

 

COUNTRY OF INCORPORATION:

 

England and Wales

 

COMPANY WEBSITE ADDRESS CONTAINING ALL INFORMATION REQUIRED BY AIM RULE 26:

 

http://www.totallyplc.com

 

COMPANY BUSINESS (INCLUDING MAIN COUNTRY OF OPERATION) OR, IN THE CASE OF AN INVESTING COMPANY, DETAILS OF ITS INVESTING POLICY). IF THE ADMISSION IS SOUGHT AS A RESULT OF A REVERSE TAKE-OVER UNDER RULE 14, THIS SHOULD BE STATED:

 

Totally plc ("Totally" or the "Company") is a provider of a range of out-of-hospital services to the healthcare sector in the UK, both to the NHS and the private sector, to help patients access healthcare services quickly, to understand healthcare options better to promote self-care and to support the NHS to manage demand across its services and to promote NHS policy of working in partnership to deliver integrated services aimed at keeping people out of hospital. The Company achieves this principally through its four existing business divisions and has a stated 'buy and build' strategy in the UK out-of-hospital healthcare sector. The Company's main country of operation is the UK.

 

The Company has conditionally agreed to acquire the entire issued share capital of Vocare Limited ("Vocare") for a maximum consideration of £11 million on a cash free and debt free basis (the "Acquisition"). The total consideration is being satisfied through:

 

(i) the payment of £6.5 million in cash on completion of the Acquisition, funded from the Company's existing cash resources;

(ii) the issue of 7,306,889 new ordinary shares at 47.9 pence per share to the vendors of Vocare ("Share Consideration"); and

(iii) deferred cash consideration of up to £1.0 million may be payable subject to the achievement of an earn out based on the EBITDA of Vocare for the year ended 31 March 2018.

 

Vocare is incorporated and registered in England and Wales and is a provider of integrated urgent care services to the NHS throughout the UK. The services provided by Vocare include urgent care centres, GP out-of-hours services, the NHS 111 service and integrated urgent care services. Other services provided include emergency dental and pharmacy services. Vocare's main country of operation is the UK.

 

Pursuant to Rule 14 of the AIM Rules for Companies, the Acquisition constitutes a reverse takeover. Shareholder approval for the Acquisition is being sought at a general meeting convened for 23 October 2017.

 

DETAILS OF SECURITIES TO BE ADMITTED INCLUDING ANY RESTRICTIONS AS TO TRANSFER OF THE SECURITIES (i.e. where known, number and type of shares, nominal value and issue price to which it seeks admission and the number and type to be held as treasury shares):

 

59,795,172 ordinary shares of 10p each ("Ordinary Shares") including 7,306,889 Ordinary Shares to be issued at 47.9p per share on admission to AIM pursuant to the Share Consideration.

 

No shares are held in treasury.

 

CAPITAL TO BE RAISED ON ADMISSION (IF APPLICABLE) AND ANTICIPATED MARKET CAPITALISATION ON ADMISSION:

 

Capital to be raised on Admission: N/A

 

Anticipated market capitalisation on Admission: £28.70 million (based on the closing mid-market share price on 21 July 2017)

 

PERCENTAGE OF AIM SECURITIES NOT IN PUBLIC HANDS AT ADMISSION:

 

15.04 per cent.

 

DETAILS OF ANY OTHER EXCHANGE OR TRADING PLATFORM TO WHICH THE AIM COMPANY HAS APPLIED OR AGREED TO HAVE ANY OF ITS SECURITIES (INCLUDING ITS AIM SECURITIES) ADMITTED OR TRADED:

 

None

 

FULL NAMES AND FUNCTIONS OF DIRECTORS AND PROPOSED DIRECTORS (underlining the first name by which each is known or including any other name by which each is known):

 

Directors:

 

Robert (Bob) Holt OBE

Chairman

Wendy Jayne Lawrence

Chief Executive Officer

Donald (Don) Ahelan Baladasan

Finance Director and Proposed Non-Executive Director

Anthony (Tony) Rhys Bourne

Non-Executive Director

Michael (Mike) Greig Rogers

Non-Executive Director

 

Proposed Director:

 

Lisa Barter-Ng

Proposed Finance Director

FULL NAMES AND HOLDINGS OF SIGNIFICANT SHAREHOLDERS EXPRESSED AS A PERCENTAGE OF THE ISSUED SHARE CAPITAL, BEFORE AND AFTER ADMISSION (underlining the first name by which each is known or including any other name by which each is known):

 

Before Admission

After Admission

Shareholder

Ordinary Shares

%

Ordinary Shares

%

Unicorn Asset Management Limited

5,759,291

10.97

5,759,291

9.63

Lombard Odier Asset Management (Europe) Limited

5,450,000

10.38

5,450,000

9.11

Miton Asset Management Limited

5,311,546

10.12

5,311,546

8.88

Legal & General Group plc

4,900,000

9.34

4,900,000

8.19

Seneca Partners Limited

3,370,545

6.42

3,370,545

5.64

Killik & Co LLP

3,222,727

6.14

3,222,727

5.39

Threadneedle Asset Management Limited

2,820,000

5.37

2,820,000

4.72

Royal London Asset Management Limited

2,800,000

5.33

2,800,000

4.68

Schroder Investment Management Limited

2,214,545

4.22

2,214,545

3.70

Canaccord Genuity Group Inc

2,155,653

4.11

2,155,653

3.61

John Joseph Harrison

-

-

2,670,647

4.47

Michael Stephen Harrison

-

-

2,670,647

4.47

 

 

NAMES OF ALL PERSONS TO BE DISCLOSED IN ACCORDANCE WITH SCHEDULE 2, PARAGRAPH (H) OF THE AIM RULES:

None

 

(i) ANTICIPATED ACCOUNTING REFERENCE DATE

(ii) DATE TO WHICH THE MAIN FINANCIAL INFORMATION IN THE ADMISSION DOCUMENT HAS BEEN PREPARED (this may be represented by unaudited interim financial information)

(iii) DATES BY WHICH IT MUST PUBLISH ITS FIRST THREE REPORTS PURSUANT TO AIM RULES 18 AND 19:

 

(i) 31 March

 

(ii) With respect to Totally, 30 June 2017 (unaudited interim financial information)

 

With respect to Vocare, 31 March 2017 (audited full year financial information)

 

(iii) 31 March 2018 (unaudited interim report for the six months ended 31 December 2017)

 

30 September 2018 (annual report for the 15 month period ended 31 March 2018)

 

31 December 2018 (unaudited interim report for the six months ended 30

September 2018)

 

EXPECTED ADMISSION DATE:

 

24 October 2017

 

NAME AND ADDRESS OF NOMINATED ADVISER:

 

Allenby Capital Limited

5 St. Helen's Place

London

EC3A 6AB

United Kingdom

 

NAME AND ADDRESS OF BROKER:

 

Allenby Capital Limited

5 St. Helen's Place

London

EC3A 6AB

United Kingdom

 

Cenkos Securities plc

6-8 Tokenhouse Yard

London

EC2R 7AS

United Kingdom

 

OTHER THAN IN THE CASE OF A QUOTED APPLICANT, DETAILS OF WHERE (POSTAL OR INTERNET ADDRESS) THE ADMISSION DOCUMENT WILL BE AVAILABLE FROM, WITH A STATEMENT THAT THIS WILL CONTAIN FULL DETAILS ABOUT THE APPLICANT AND THE ADMISSION OF ITS SECURITIES:

 

Copies of the admission document, which will contain full details about the Company and the admission of its securities, will be available from the registered office of the Company and at the offices of Allenby Capital Limited, 5 St. Helen's Place, London EC3A 6AB during normal business hours on any weekday (Saturdays, Sundays and public holidays excepted) for a period of one month from the date of admission.

 

The admission document will also be available to download from the Company's website www.totallyplc.com

 

DATE OF NOTIFICATION:

 

6 October 2017

 

NEW/ UPDATE:

 

NEW

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
PAAEAKEKELFXFEF
Date   Source Headline
11th Mar 20247:00 amRNSContract win
7th Mar 20246:00 pmRNSHolding(s) in Company
5th Feb 20247:00 amRNSDirector/PDMR Shareholding
1st Feb 20243:00 pmRNSDirectorate Change
10th Jan 20247:00 amRNSContract Extension
8th Dec 20233:30 pmRNSHolding(s) in Company
6th Dec 20237:00 amRNSDirector/PDMR Shareholding
4th Dec 20235:45 pmRNSHolding(s) in Company
1st Dec 20239:33 amRNSDirector/PDMR Shareholding
1st Dec 20237:00 amRNSDirector/PDMR Shareholding
30th Nov 20237:00 amRNSDirector/PDMR Shareholding
28th Nov 20237:00 amRNSAdviser Update
28th Nov 20237:00 amRNSDirectorate Change
28th Nov 20237:00 amRNSInterim Results
22nd Nov 20237:00 amRNSNotice of Interim Results & Investor Presentation
4th Oct 20234:15 pmRNSHolding(s) in Company
11th Sep 202312:00 pmRNSExercise of options and change to TVR
1st Sep 202312:25 pmRNSResult of AGM
1st Sep 20237:00 amRNSAGM Statement
25th Jul 20237:00 amRNSHolding(s) in Company
18th Jul 20234:00 pmRNSExercise of options and change to TVR
13th Jul 20233:30 pmRNSHolding(s) in Company
12th Jul 202312:15 pmRNSHolding(s) in Company
12th Jul 20237:00 amRNSDividend Timetable and EPS - Corrections
11th Jul 20237:00 amRNSHolding(s) in Company
10th Jul 20237:00 amRNSPreliminary results
6th Jul 20237:00 amRNSNotice of Preliminary Results
5th Jul 20231:00 pmRNSExercise of options and change to TVR
22nd May 20237:00 amRNSTotally secures multiple contract extensions
16th May 202312:30 pmRNSExercise of options & change to TVR
2nd May 20237:01 amRNSTrading Update for 12 months ending 31 March 2023
2nd May 20237:00 amRNSAppointment of Nomad and Joint Corporate Broker
26th Apr 20237:00 amRNSFurther new contract win for urology services
18th Apr 20237:00 amRNSTotally to help reduce waiting lists in Wales
12th Apr 20237:00 amRNSTotally wins new contract for urology services
4th Apr 20237:00 amRNSTotally first to fully mobilise on NHS SVCC model
31st Mar 20235:00 pmRNSTotal Voting Rights
31st Mar 20237:00 amRNSDirector/PDMR Shareholding
20th Mar 20231:42 pmRNSExercise of options, PDMR shareholding & TVR
16th Mar 20231:34 pmRNSDirector/PDMR Shareholding
10th Mar 20231:49 pmRNSHolding(s) in Company
10th Mar 20237:00 amRNSHolding(s) in Company
8th Mar 20232:09 pmRNSDirector/PDMR Shareholding
2nd Mar 20239:05 amRNSSecond Price Monitoring Extn
2nd Mar 20239:00 amRNSPrice Monitoring Extension
2nd Mar 20237:00 amRNSTrading Update
28th Feb 20235:00 pmRNSTotal Voting Rights
3rd Feb 20234:41 pmRNSExercise of options, director/PDMR & TVR
2nd Feb 20238:48 amRNSEmployee Benefit Trust share transfer
31st Jan 20235:00 pmRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.